Interestingly, we recently found that the human ANGPTL2 minimal promoter (−168 to +98) also contains a putative CRE site essential for ANGPTL2 expression and that ATF2 binds to this site in human lung cancer cells [13]. This evidence concerns the gene ANGPTL2 and lung carcinoma.